nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—lung cancer—adrenal gland cancer	0.554	1	CtDrD
Gefitinib—EGFR—adrenal gland cancer	0.256	0.767	CbGaD
Gefitinib—ABCB1—adrenal gland cancer	0.0779	0.233	CbGaD
Gefitinib—STK10—renal vein—adrenal gland cancer	0.0123	0.271	CbGeAlD
Gefitinib—STK10—renal artery—adrenal gland cancer	0.00827	0.182	CbGeAlD
Gefitinib—HIPK4—gonad—adrenal gland cancer	0.00122	0.0269	CbGeAlD
Gefitinib—SBK1—pituitary gland—adrenal gland cancer	0.00121	0.0265	CbGeAlD
Gefitinib—CYP2C19—urine—adrenal gland cancer	0.00119	0.0261	CbGeAlD
Gefitinib—CHEK2—pituitary gland—adrenal gland cancer	0.00105	0.0231	CbGeAlD
Gefitinib—Lapatinib—EGFR—adrenal gland cancer	0.00104	0.277	CrCbGaD
Gefitinib—EPHA6—gonad—adrenal gland cancer	0.000965	0.0212	CbGeAlD
Gefitinib—CHEK2—adrenal gland—adrenal gland cancer	0.000938	0.0206	CbGeAlD
Gefitinib—CYP2C9—urine—adrenal gland cancer	0.000921	0.0203	CbGeAlD
Gefitinib—CSNK1E—adrenal cortex—adrenal gland cancer	0.000824	0.0181	CbGeAlD
Gefitinib—IRAK4—adrenal cortex—adrenal gland cancer	0.000811	0.0178	CbGeAlD
Gefitinib—MKNK2—adrenal cortex—adrenal gland cancer	0.000756	0.0166	CbGeAlD
Gefitinib—MKNK1—adrenal cortex—adrenal gland cancer	0.000746	0.0164	CbGeAlD
Gefitinib—Afatinib—EGFR—adrenal gland cancer	0.000734	0.196	CrCbGaD
Gefitinib—CYP3A4—urine—adrenal gland cancer	0.000702	0.0154	CbGeAlD
Gefitinib—CYP2D6—urine—adrenal gland cancer	0.000691	0.0152	CbGeAlD
Gefitinib—CSNK1E—pituitary gland—adrenal gland cancer	0.000666	0.0146	CbGeAlD
Gefitinib—IRAK4—pituitary gland—adrenal gland cancer	0.000655	0.0144	CbGeAlD
Gefitinib—MKNK2—gonad—adrenal gland cancer	0.000626	0.0138	CbGeAlD
Gefitinib—MKNK2—cardiac atrium—adrenal gland cancer	0.000625	0.0138	CbGeAlD
Gefitinib—EGFR—adrenal gland—adrenal gland cancer	0.000618	0.0136	CbGeAlD
Gefitinib—MKNK1—gonad—adrenal gland cancer	0.000618	0.0136	CbGeAlD
Gefitinib—MKNK1—cardiac atrium—adrenal gland cancer	0.000617	0.0136	CbGeAlD
Gefitinib—MKNK2—pituitary gland—adrenal gland cancer	0.000611	0.0134	CbGeAlD
Gefitinib—MKNK1—pituitary gland—adrenal gland cancer	0.000603	0.0133	CbGeAlD
Gefitinib—CSNK1E—adrenal gland—adrenal gland cancer	0.000595	0.0131	CbGeAlD
Gefitinib—IRAK4—adrenal gland—adrenal gland cancer	0.000585	0.0129	CbGeAlD
Gefitinib—MAP2K5—adrenal cortex—adrenal gland cancer	0.000549	0.0121	CbGeAlD
Gefitinib—MKNK2—adrenal gland—adrenal gland cancer	0.000546	0.012	CbGeAlD
Gefitinib—IRAK1—adrenal gland—adrenal gland cancer	0.000546	0.012	CbGeAlD
Gefitinib—MKNK1—adrenal gland—adrenal gland cancer	0.000539	0.0119	CbGeAlD
Gefitinib—Erlotinib—EGFR—adrenal gland cancer	0.000519	0.139	CrCbGaD
Gefitinib—STK10—gonad—adrenal gland cancer	0.000509	0.0112	CbGeAlD
Gefitinib—MAP2K5—cardiac atrium—adrenal gland cancer	0.000454	0.00999	CbGeAlD
Gefitinib—STK10—adrenal gland—adrenal gland cancer	0.000444	0.00976	CbGeAlD
Gefitinib—MAP2K5—pituitary gland—adrenal gland cancer	0.000444	0.00976	CbGeAlD
Gefitinib—MAP2K5—adrenal gland—adrenal gland cancer	0.000396	0.00872	CbGeAlD
Gefitinib—Vandetanib—EGFR—adrenal gland cancer	0.000342	0.0913	CrCbGaD
Gefitinib—Bosutinib—EGFR—adrenal gland cancer	0.00032	0.0854	CrCbGaD
Gefitinib—Lapatinib—ABCB1—adrenal gland cancer	0.000315	0.0842	CrCbGaD
Gefitinib—ALB—adrenal gland—adrenal gland cancer	0.000282	0.00621	CbGeAlD
Gefitinib—ABCG2—adrenal cortex—adrenal gland cancer	0.000267	0.00587	CbGeAlD
Gefitinib—Afatinib—ABCB1—adrenal gland cancer	0.000223	0.0597	CrCbGaD
Gefitinib—ABCG2—pituitary gland—adrenal gland cancer	0.000216	0.00475	CbGeAlD
Gefitinib—CYP1A1—cardiac atrium—adrenal gland cancer	0.00021	0.00461	CbGeAlD
Gefitinib—ABCG2—adrenal gland—adrenal gland cancer	0.000193	0.00424	CbGeAlD
Gefitinib—Erlotinib—ABCB1—adrenal gland cancer	0.000158	0.0421	CrCbGaD
Gefitinib—ABCB1—adrenal cortex—adrenal gland cancer	0.000132	0.0029	CbGeAlD
Gefitinib—ABCB1—gonad—adrenal gland cancer	0.000109	0.0024	CbGeAlD
Gefitinib—ABCB1—pituitary gland—adrenal gland cancer	0.000106	0.00234	CbGeAlD
Gefitinib—Bosutinib—ABCB1—adrenal gland cancer	9.72e-05	0.026	CrCbGaD
Gefitinib—ABCB1—adrenal gland—adrenal gland cancer	9.5e-05	0.00209	CbGeAlD
Gefitinib—EGFR—Innate Immune System—CDC42—adrenal gland cancer	2.01e-05	0.000318	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TP53—adrenal gland cancer	2e-05	0.000317	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.99e-05	0.000315	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CDC42—adrenal gland cancer	1.94e-05	0.000307	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CDC42—adrenal gland cancer	1.93e-05	0.000305	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SDHB—adrenal gland cancer	1.92e-05	0.000304	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—EGFR—adrenal gland cancer	1.91e-05	0.000303	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SPRY2—adrenal gland cancer	1.9e-05	0.000302	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TP53—adrenal gland cancer	1.9e-05	0.000302	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.89e-05	0.000299	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TSHR—adrenal gland cancer	1.86e-05	0.000294	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—BAD—adrenal gland cancer	1.84e-05	0.000291	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TERT—adrenal gland cancer	1.84e-05	0.000291	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—RRM1—adrenal gland cancer	1.83e-05	0.00029	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SDHD—adrenal gland cancer	1.83e-05	0.00029	CbGpPWpGaD
Gefitinib—EGFR—Disease—SPRY2—adrenal gland cancer	1.82e-05	0.000288	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—SPARC—adrenal gland cancer	1.79e-05	0.000284	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	1.79e-05	0.000284	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CDC42—adrenal gland cancer	1.78e-05	0.000282	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—BAD—adrenal gland cancer	1.77e-05	0.000281	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—adrenal gland cancer	1.77e-05	0.00028	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	1.76e-05	0.000279	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SDHB—adrenal gland cancer	1.75e-05	0.000277	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CDC42—adrenal gland cancer	1.75e-05	0.000277	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MEN1—adrenal gland cancer	1.74e-05	0.000277	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.72e-05	0.000273	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IGF2—adrenal gland cancer	1.72e-05	0.000272	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.71e-05	0.000271	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—GNAS—adrenal gland cancer	1.7e-05	0.00027	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.7e-05	0.000269	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.69e-05	0.000268	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PTGS2—adrenal gland cancer	1.68e-05	0.000266	CbGpPWpGaD
Gefitinib—EGFR—Disease—MEN1—adrenal gland cancer	1.67e-05	0.000264	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PRKACA—adrenal gland cancer	1.66e-05	0.000263	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IGF1R—adrenal gland cancer	1.66e-05	0.000263	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CTNNB1—adrenal gland cancer	1.65e-05	0.000262	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TP53—adrenal gland cancer	1.64e-05	0.000261	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—EGFR—adrenal gland cancer	1.64e-05	0.000261	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	1.62e-05	0.000256	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—BRAF—adrenal gland cancer	1.62e-05	0.000256	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	1.6e-05	0.000254	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PRKACA—adrenal gland cancer	1.6e-05	0.000254	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—BAD—adrenal gland cancer	1.6e-05	0.000253	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SDHB—adrenal gland cancer	1.57e-05	0.000249	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TERT—adrenal gland cancer	1.55e-05	0.000246	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.55e-05	0.000245	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.53e-05	0.000243	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—TP53—adrenal gland cancer	1.51e-05	0.00024	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—PRKACA—adrenal gland cancer	1.51e-05	0.00024	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.51e-05	0.00024	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—PRKACA—adrenal gland cancer	1.51e-05	0.000239	CbGpPWpGaD
Gefitinib—MKNK1—Disease—CTNNB1—adrenal gland cancer	1.5e-05	0.000238	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.48e-05	0.000235	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—POMC—adrenal gland cancer	1.47e-05	0.000234	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—BAD—adrenal gland cancer	1.46e-05	0.000232	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—BRAF—adrenal gland cancer	1.45e-05	0.000231	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SDHB—adrenal gland cancer	1.45e-05	0.000229	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SDHB—adrenal gland cancer	1.43e-05	0.000227	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TERT—adrenal gland cancer	1.43e-05	0.000226	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CDC42—adrenal gland cancer	1.41e-05	0.000223	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—BAD—adrenal gland cancer	1.4e-05	0.000222	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GNRH1—adrenal gland cancer	1.39e-05	0.000221	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.38e-05	0.000218	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CTNNB1—adrenal gland cancer	1.38e-05	0.000218	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PRKACA—adrenal gland cancer	1.38e-05	0.000218	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MED12—adrenal gland cancer	1.36e-05	0.000216	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CDC42—adrenal gland cancer	1.36e-05	0.000215	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IGF2—adrenal gland cancer	1.36e-05	0.000215	CbGpPWpGaD
Gefitinib—ERBB3—Disease—BAD—adrenal gland cancer	1.35e-05	0.000214	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—GNAS—adrenal gland cancer	1.34e-05	0.000213	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—BAD—adrenal gland cancer	1.34e-05	0.000213	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PRKACA—adrenal gland cancer	1.33e-05	0.000211	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IGF1R—adrenal gland cancer	1.31e-05	0.000208	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—EGFR—adrenal gland cancer	1.31e-05	0.000208	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.31e-05	0.000208	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—RRM1—adrenal gland cancer	1.31e-05	0.000208	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SDHD—adrenal gland cancer	1.31e-05	0.000208	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IGF2—adrenal gland cancer	1.31e-05	0.000207	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PTGS2—adrenal gland cancer	1.3e-05	0.000207	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—GNAS—adrenal gland cancer	1.3e-05	0.000206	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—CDC42—adrenal gland cancer	1.28e-05	0.000203	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CDC42—adrenal gland cancer	1.28e-05	0.000203	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SPRY2—adrenal gland cancer	1.27e-05	0.000202	CbGpPWpGaD
Gefitinib—EGFR—Disease—PRKACA—adrenal gland cancer	1.27e-05	0.000202	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IGF1R—adrenal gland cancer	1.26e-05	0.0002	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—EGFR—adrenal gland cancer	1.26e-05	0.0002	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.26e-05	0.000199	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—BAD—adrenal gland cancer	1.24e-05	0.000197	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSHR—adrenal gland cancer	1.24e-05	0.000197	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—RRM1—adrenal gland cancer	1.24e-05	0.000196	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SDHD—adrenal gland cancer	1.24e-05	0.000196	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IGF2—adrenal gland cancer	1.24e-05	0.000196	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.24e-05	0.000196	CbGpPWpGaD
Gefitinib—ERBB3—Disease—BRAF—adrenal gland cancer	1.23e-05	0.000195	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—GNAS—adrenal gland cancer	1.23e-05	0.000194	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—GNAS—adrenal gland cancer	1.22e-05	0.000194	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—BAD—adrenal gland cancer	1.22e-05	0.000193	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CTNNB1—adrenal gland cancer	1.21e-05	0.000192	CbGpPWpGaD
Gefitinib—MKNK1—Disease—EGFR—adrenal gland cancer	1.19e-05	0.000189	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CDC42—adrenal gland cancer	1.17e-05	0.000185	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CTNNB1—adrenal gland cancer	1.17e-05	0.000185	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MEN1—adrenal gland cancer	1.17e-05	0.000185	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.15e-05	0.000182	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—POMC—adrenal gland cancer	1.15e-05	0.000182	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—BRAF—adrenal gland cancer	1.13e-05	0.000179	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CDC42—adrenal gland cancer	1.13e-05	0.000179	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TERT—adrenal gland cancer	1.13e-05	0.000179	CbGpPWpGaD
Gefitinib—ALB—Metabolism—RRM1—adrenal gland cancer	1.13e-05	0.000179	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SDHD—adrenal gland cancer	1.13e-05	0.000179	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.13e-05	0.000179	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.13e-05	0.000178	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—EGFR—adrenal gland cancer	1.09e-05	0.000173	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IGF2—adrenal gland cancer	1.09e-05	0.000173	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TERT—adrenal gland cancer	1.09e-05	0.000173	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—GNAS—adrenal gland cancer	1.08e-05	0.000171	CbGpPWpGaD
Gefitinib—EGFR—Disease—CDC42—adrenal gland cancer	1.08e-05	0.000171	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.06e-05	0.000168	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.06e-05	0.000168	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IGF1R—adrenal gland cancer	1.05e-05	0.000167	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.05e-05	0.000167	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CTNNB1—adrenal gland cancer	1.04e-05	0.000165	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.04e-05	0.000165	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—RRM1—adrenal gland cancer	1.01e-05	0.000161	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SDHD—adrenal gland cancer	1.01e-05	0.000161	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—adrenal gland cancer	9.94e-06	0.000158	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PRKACA—adrenal gland cancer	9.94e-06	0.000158	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SDHD—adrenal gland cancer	9.88e-06	0.000157	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—RRM1—adrenal gland cancer	9.88e-06	0.000157	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—BAD—adrenal gland cancer	9.82e-06	0.000156	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MED12—adrenal gland cancer	9.76e-06	0.000155	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CTNNB1—adrenal gland cancer	9.64e-06	0.000153	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—EGFR—adrenal gland cancer	9.57e-06	0.000152	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—BAD—adrenal gland cancer	9.47e-06	0.00015	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	9.45e-06	0.00015	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SDHD—adrenal gland cancer	9.31e-06	0.000148	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—RRM1—adrenal gland cancer	9.31e-06	0.000148	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.3e-06	0.000147	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—EGFR—adrenal gland cancer	9.25e-06	0.000147	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—RRM1—adrenal gland cancer	9.23e-06	0.000146	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SDHD—adrenal gland cancer	9.23e-06	0.000146	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MED12—adrenal gland cancer	9.23e-06	0.000146	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CTNNB1—adrenal gland cancer	9.21e-06	0.000146	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TERT—adrenal gland cancer	9.06e-06	0.000144	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—POMC—adrenal gland cancer	9.06e-06	0.000144	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—BRAF—adrenal gland cancer	8.94e-06	0.000142	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.92e-06	0.000141	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRKACA—adrenal gland cancer	8.9e-06	0.000141	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CTNNB1—adrenal gland cancer	8.9e-06	0.000141	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—adrenal gland cancer	8.73e-06	0.000138	CbGpPWpGaD
Gefitinib—EGFR—Disease—TERT—adrenal gland cancer	8.65e-06	0.000137	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—BRAF—adrenal gland cancer	8.62e-06	0.000137	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MED12—adrenal gland cancer	8.41e-06	0.000133	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EGFR—adrenal gland cancer	8.33e-06	0.000132	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.25e-06	0.000131	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—adrenal gland cancer	8.23e-06	0.00013	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CTNNB1—adrenal gland cancer	8.18e-06	0.00013	CbGpPWpGaD
Gefitinib—EGFR—Immune System—BAD—adrenal gland cancer	8.15e-06	0.000129	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GNAS—adrenal gland cancer	8.06e-06	0.000128	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CTNNB1—adrenal gland cancer	8.02e-06	0.000127	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ABCB1—adrenal gland cancer	7.91e-06	0.000125	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—BAD—adrenal gland cancer	7.88e-06	0.000125	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—EGFR—adrenal gland cancer	7.63e-06	0.000121	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CDC42—adrenal gland cancer	7.55e-06	0.00012	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MED12—adrenal gland cancer	7.55e-06	0.00012	CbGpPWpGaD
Gefitinib—EGFR—Disease—BAD—adrenal gland cancer	7.53e-06	0.000119	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.52e-06	0.000119	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.49e-06	0.000119	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MED12—adrenal gland cancer	7.37e-06	0.000117	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF2—adrenal gland cancer	7.28e-06	0.000115	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—adrenal gland cancer	7.27e-06	0.000115	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GNAS—adrenal gland cancer	7.22e-06	0.000114	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—BRAF—adrenal gland cancer	7.18e-06	0.000114	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	7.12e-06	0.000113	CbGpPWpGaD
Gefitinib—ERBB3—Disease—EGFR—adrenal gland cancer	7.05e-06	0.000112	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF1R—adrenal gland cancer	7.04e-06	0.000112	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—adrenal gland cancer	6.99e-06	0.000111	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MED12—adrenal gland cancer	6.94e-06	0.00011	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MED12—adrenal gland cancer	6.88e-06	0.000109	CbGpPWpGaD
Gefitinib—EGFR—Disease—BRAF—adrenal gland cancer	6.85e-06	0.000109	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.75e-06	0.000107	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	6.73e-06	0.000107	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.58e-06	0.000104	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EGFR—adrenal gland cancer	6.48e-06	0.000103	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CTNNB1—adrenal gland cancer	6.46e-06	0.000102	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—EGFR—adrenal gland cancer	6.36e-06	0.000101	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CTNNB1—adrenal gland cancer	6.23e-06	9.88e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.15e-06	9.75e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PRKACA—adrenal gland cancer	6.13e-06	9.73e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	6.09e-06	9.65e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	6.09e-06	9.65e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TERT—adrenal gland cancer	6.06e-06	9.61e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6e-06	9.51e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GNAS—adrenal gland cancer	5.77e-06	9.15e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	5.67e-06	8.98e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—adrenal gland cancer	5.54e-06	8.77e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	5.51e-06	8.73e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GNAS—adrenal gland cancer	5.45e-06	8.65e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—adrenal gland cancer	5.44e-06	8.62e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—adrenal gland cancer	5.43e-06	8.6e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.38e-06	8.53e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	5.38e-06	8.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CTNNB1—adrenal gland cancer	5.36e-06	8.5e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	5.35e-06	8.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—BAD—adrenal gland cancer	5.27e-06	8.36e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.19e-06	8.22e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EGFR—adrenal gland cancer	5.12e-06	8.12e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	5.07e-06	8.03e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	5.02e-06	7.96e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GNAS—adrenal gland cancer	4.97e-06	7.88e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CTNNB1—adrenal gland cancer	4.95e-06	7.85e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EGFR—adrenal gland cancer	4.94e-06	7.82e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	4.91e-06	7.78e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCB1—adrenal gland cancer	4.88e-06	7.73e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—adrenal gland cancer	4.86e-06	7.7e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—BRAF—adrenal gland cancer	4.8e-06	7.61e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MED12—adrenal gland cancer	4.54e-06	7.2e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GNAS—adrenal gland cancer	4.46e-06	7.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	4.38e-06	6.94e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GNAS—adrenal gland cancer	4.36e-06	6.91e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—adrenal gland cancer	4.33e-06	6.86e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—adrenal gland cancer	4.3e-06	6.82e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—adrenal gland cancer	4.14e-06	6.57e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EGFR—adrenal gland cancer	4.11e-06	6.51e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GNAS—adrenal gland cancer	4.11e-06	6.51e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GNAS—adrenal gland cancer	4.07e-06	6.45e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	4.03e-06	6.39e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	3.99e-06	6.33e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—adrenal gland cancer	3.92e-06	6.21e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—adrenal gland cancer	3.89e-06	6.16e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—adrenal gland cancer	3.67e-06	5.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CTNNB1—adrenal gland cancer	3.47e-06	5.5e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—adrenal gland cancer	3.45e-06	5.47e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—adrenal gland cancer	3.35e-06	5.31e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	3.31e-06	5.25e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	3.1e-06	4.92e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—adrenal gland cancer	3.01e-06	4.76e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—adrenal gland cancer	2.93e-06	4.65e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	2.93e-06	4.64e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—adrenal gland cancer	2.76e-06	4.38e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—adrenal gland cancer	2.74e-06	4.34e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	2.68e-06	4.25e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—adrenal gland cancer	2.67e-06	4.23e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	2.63e-06	4.18e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	2.4e-06	3.8e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.34e-06	3.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—adrenal gland cancer	2.31e-06	3.66e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	2.2e-06	3.5e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	2.19e-06	3.46e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.81e-06	2.86e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.44e-06	2.29e-05	CbGpPWpGaD
